pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
AMICUS THERAPEUTICS, INC. ($FOLD) · news · pharmadog
← back to AMICUS THERAPEUTICS, INC.
News mentioning $FOLD
39
stories
3d
Foghorn cuts 40% of workforce
biospace
3d
Sarepta could be ‘potential turnaround story’ with catalysts lined up into 2027
biospace
4d
HHS kicks off new programs to speed clinical trials as Chinese competition looms
biopharma dive
4d
Trump administration appeals ruling blocking limits on international student visas
stat
4d
Opinion: I studied GLP-1 use in children. The results are reassuring
stat
10d
Travere CEO Eric Dube on deciding to leave; Roche tees up a board seat for ex-Takeda chief
endpoints
10d
At least five candidates vie to become the next WHO leader, as questions over U.S. role loom
stat
11d
FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’
biospace
12d
Novo’s turnaround plan, weight loss wins, Ultragenyx’s Sanfilippo approval, IPO blitz
biospace
13d
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
biospace
14d
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
biospace
18d
STAT+: Why do ‘never-smokers’ get lung cancer? In some cases, rare genetic variant may be a factor
stat
18d
Opinion: What happened to oppositional defiant disorder?
stat
27d
Sandoz unveils plan for biosimilar expansion and new $300M factory in Slovenia
endpoints
27d
An administrative gap delays access to new pancreatic cancer treatment
stat
Sep 4, 26
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
biospace
Sep 3, 26
STAT+: Seattle scientists launch $95 million AI biology effort
stat
Sep 3, 26
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
biospace
Aug 27, 26
Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerate
biospace
Aug 26, 26
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
biopharma dive
Aug 25, 26
McKesson strikes $2.25B deal to snap up Precision Medicine Group
fiercebiotech
Aug 21, 26
Novo Nordisk starts trialing lower maintenance doses of oral Wegovy
biospace
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 19, 26
Novo takes first round of oral obesity duel. Can it stay ahead of Lilly?
biospace
Aug 12, 26
AI clinical monitoring agent can deliver up to 82 times the ROI in oncology: report
fiercebiotech
Aug 11, 26
After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
fiercebiotech
Aug 4, 26
The China Debate: Biotech deserves a deeper discussion
endpoints
Jul 29, 26
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
Jul 27, 26
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
fiercebiotech
Jul 18, 26
Opinion: STAT readers on the value of primary care, obesity as a disease, and more
stat
← prev
page 1 of 2
next →
